Joseph C Sardano
CIK 1300111 · CHIEF EXECUTIVE OFFICER · last filed 2026-08-24
Joseph C Sardano is a CHIEF EXECUTIVE OFFICER who has filed 27 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing shows the insider bought $60.5K of SRTS on Aug 24, 2026. Across all open-market trades the lifetime net is −$5.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SRTS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BOCA RATON, FL 33487
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRTS | CHIEF EXECUTIVE OFFICER | 1,220,293 | $2.95 | $3.60M | -$4.46M | 12 | 2026-08-24 |
| Sensus Healthcare, Inc. (SRTSW) Delisted | CHIEF EXECUTIVE OFFICER | 1,538,649 | — | — | -$698.8K | 15 | 2018-09-12 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-24 | SRTS | Buy (P) | +20,000 | $60.5K | EDGAR |
| 2025-11-19 | SRTS | Buy (P) | +25,000 | $100.8K | EDGAR |
| 2023-09-18 | SRTS | Buy (P) | +10,000 | $28.8K | EDGAR |
| 2023-08-08 | SRTS | Buy (P) | +10,000 | $38.6K | EDGAR |
| 2023-05-11 | SRTS | Buy (P) | +25,000 | $74.8K | EDGAR |
| 2022-09-07 | SRTS | Sell (S) | −41,588 | -$521.3K | EDGAR |
| 2022-08-11 | SRTS | Sell (S) | −158,412 | -$2.24M | EDGAR |
| 2022-03-11 | SRTS | Sell (S) | −133,356 | -$1.35M | EDGAR |
| 2021-12-17 | SRTS | Sell (S) | −24,227 | -$169.6K | EDGAR |
| 2021-12-16 | SRTS | Sell (S) | −18,572 | -$133.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.